v24.6.28

Broaden the CLSI B. cepacia comples breakpoints to apply to the "BCX" species group instead of the "species"-level code only.
Adds breakpoints for several drugs which were not defined by CLSI, but were defined by FDA to the CLSI 2024 breakpoint set (does not implement FDA as its own separate guideline type).